In hepatocellular carcinoma, miR‐194 inhibits PTBP1 expression by binding to the 3′‐UTR of PTBP1 mRNA, leading to a decrease in cell cycle protein D3 (CCND3) protein levels, which affects the cell cycle and tumour progression [143]. This evidence concerns the gene PTBP1 and neoplasm.